The Scientist

» innovation, disease/medicine and immunology

Most Recent

image: Week in Review: April 1-5

Week in Review: April 1-5

By | April 5, 2013

Living fossils not so fossilized; Canadian gov’t threatens scientists’ freedom to speak and publish; gene therapy for sensory disorders; an unusual theory of cancer; clues for an HIV vaccine

0 Comments

image: Cancer Growth Curtailed

Cancer Growth Curtailed

By | April 4, 2013

Researchers develop two small molecules that slow the growth of human cancer cells.

0 Comments

image: Roadmap to an HIV Vaccine

Roadmap to an HIV Vaccine

By | April 3, 2013

Researchers track the evolution of HIV in a single patient to understand what drives the production of broadly neutralizing antibodies.

0 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Contributors

Contributors

By | April 1, 2013

Meet some of the people featured in the April 2013 issue of The Scientist.

0 Comments

image: Making Cancer More Transparent

Making Cancer More Transparent

By | April 1, 2013

A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.

3 Comments

image: Mimicking Mussels

Mimicking Mussels

By | April 1, 2013

Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.

1 Comment

image: Up, Up, and Array

Up, Up, and Array

By | April 1, 2013

By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.

1 Comment

image: After Chemo

After Chemo

By | April 1, 2013

Research into how the brain suffers as a result of chemotherapy is revealing potential avenues for ameliorating cognitive decline.

1 Comment

image: Sensing Gene Therapy

Sensing Gene Therapy

By | March 31, 2013

Scientists are using genetic techniques to target diseases that affect how we see, hear, smell, taste, and feel.

1 Comment

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham